Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia

被引:4
|
作者
Korac, Petra [1 ]
Ajdukovic, Radmila [2 ]
Paro, Mirjana Mariana Kardum [3 ]
Jaksic, Branimir [4 ]
Dominis, Mara [1 ]
机构
[1] Univ Zagreb, Univ Hosp Merkur, Dept Pathol & Cytol, Zagreb 10000, Croatia
[2] Univ Zagreb, Dubrava Univ Hosp, Dept Med, Zagreb, Croatia
[3] Univ Zagreb, Univ Hosp Merkur, Inst Clin Chem, Zagreb 10000, Croatia
[4] Univ Zagreb, Univ Hosp Merkur, Dept Med, Zagreb 10000, Croatia
关键词
CLL; ZAP-70; CD45RO; Immunohistochemistry; Double immunofluorescence; Prognosis; VARIABLE-REGION MUTATIONS; CD38; EXPRESSION; GENE MUTATION; PROGNOSTIC-FACTOR; DISEASE; QUANTIFICATION; DIAGNOSIS; SURVIVAL;
D O I
10.1007/s10735-009-9213-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This paper shows a protocol for the detection of ZAP-70 expression in B-CLL (B cell chronic lymphocytic leukemia) tumor cells by common immunohistochemical methods. The study was conducted on bone marrow trephine biopsies from 62 B-CLL patients at the time of diagnosis. Immunohistochemical reactions based on peroxidase and alkaline phosphatase reactions were used, as well as double immunofluorescent labeling for ZAP-70 detection as an indirect marker of mutated and unmutated CLL. Clinical relevance of the ZAP-70 expression detection method was assessed using chi (2) test between ZAP-70 positivity data and other known prognostic factors, i.e., clinical and cytogenetics data. ZAP-70 was detected in 13 out of 62 patients. Statistically significant results were obtained for ZAP-70 positive cases and known indicators of worse prognosis. Immunohistochemical analysis supported by double immunfluorescent labeling, as shown here, is an easy and reliable technique for the detection of ZAP-70 expression in B-CLL tumor cells applicable in every hematopathology laboratory.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 50 条
  • [41] Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia
    Del Principe, Maria Ilaria
    Del Poeta, Giovanni
    Buccisano, Francesco
    Maurillo, Luca
    Venditti, Adriano
    Zucchetto, Antonella
    Marini, Rita
    Niscola, Pasquale
    Consalvo, Maria Antonietta Irno
    Mazzone, Carla
    Ottaviani, Licia
    Panetta, Paola
    Bruno, Antonio
    Bomben, Riccardo
    Suppo, Giovanna
    Degan, Massimo
    Gattei, Valter
    de Fabritiis, Paolo
    Cantonetti, Maria
    Lo Coco, Francesco
    Del Principe, Domenico
    Amadori, Sergio
    BLOOD, 2006, 108 (03) : 853 - 861
  • [42] Chronic lymphocytic leukemia (CLL) with discordance in ZAP-70 expression and IgVH mutation status.
    Del Giudice, Ilaria
    Ghia, Emanuela M.
    De Propris, Stefania M.
    Marinelli, Marilisa
    Nanni, Mauro
    Mancini, Francesca
    Gentile, Massimo
    Giammartini, Elena
    Calabrese, Elisabetta
    Mauro, Francesca R.
    Guarini, Anna
    Foa, Robert
    BLOOD, 2006, 108 (11) : 789A - 789A
  • [43] Smudge cell percentage as a surrogate marker for ZAP-70 expression in patients with chronic lymphocytic leukemia
    Al-Kahiry, Waiel
    Tawfik, Hadeel Said
    Sharshira, Homam
    Ghanem, Amal
    El-Gammal, Maha
    Mikhael, Irene Lewis
    BLOOD RESEARCH, 2018, 53 (03) : 218 - 222
  • [44] Prognostic significance of Zap-70 expression in B-cell chronic lymphocytic leukemia (CLL).
    Kowal, M
    Dmoszynska, A
    Bojarska-Junak, A
    Rolinski, J
    Wawrzaszek, P
    BLOOD, 2003, 102 (11) : 349B - 350B
  • [45] ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
    Crespo, M
    Bosch, F
    Villamor, N
    Bellosillo, B
    Colomer, D
    Rozman, M
    Marcé, S
    López-Guillermo, A
    Campo, E
    Montserrat, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18): : 1764 - 1775
  • [46] CLINICAL AND IMMUNOLOGICAL CHARACTERISTIC OF ZAP-70POSSITIVE AND ZAP-70 NEGATIVE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Wasik-Szczepanek, E.
    Bojarska-Junak, A.
    Koczkodaj, D.
    Hus, I.
    Hus, I.
    Dmoszynska, A.
    Wach, M.
    Szczepanek, D.
    Adamczyk-Cioch, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 526 - 526
  • [47] ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia
    Vener, C
    Gianelli, U
    Cortelezzi, A
    Fracchiolla, NS
    Somalvico, F
    Savi, F
    Pasquini, MC
    Bosari, S
    Deliliers, GL
    LEUKEMIA & LYMPHOMA, 2006, 47 (02) : 245 - 251
  • [48] Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients
    Gogia, A.
    Sharma, A.
    Raina, V
    Kumar, L.
    Gupta, R.
    Kumar, R.
    INDIAN JOURNAL OF CANCER, 2013, 50 (04) : 333 - 336
  • [49] Parallel evaluation of commercial antibodies for Zap-70 in chronic lymphocytic leukemia (CLL).
    Bakke, A
    Purtzer, Z
    Huang, J
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2004, 62B (01): : 60 - 60
  • [50] Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia
    D'Arena, Giovanni
    Tarnani, Michela
    Rumi, Carlo
    Vaisitti, Tiziana
    Aydin, Sernra
    De Filippi, Rosaria
    Perrone, Francesco
    Pinto, Antonio
    Chiusolo, Patrizia
    Deaglio, Silvia
    Malavasi, Fabio
    Laurentl, Luca
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (09) : 787 - 791